CreativeOne Wealth’s GSK GSK Stock Holding History

CreativeOne Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$377K	Sell	6,838 -382	-5%	-$20.7K	0.01%	897
2025 Q4	$354K	Buy	7,220 +533	+8%	+$24.9K	0.01%	892
2025 Q3	$289K	Buy	6,687 +1,455	+28%	+$56.8K	0.01%	964
2025 Q2	$201K	Sell	5,232 -67	-1%	-$2.56K	0.01%	1060
2025 Q1	$205K	Buy	+5,299	New	+$194K	0.01%	995
2024 Q4	–	Sell	-5,209	Closed	-$213K	–	1090
2024 Q3	$213K	Buy	+5,209	New	+$213K	0.01%	887
2024 Q2	–	Sell	-5,487	Closed	-$235K	–	831
2024 Q1	$235K	Buy	+5,487	New	+$226K	0.01%	794
2023 Q4	–	Sell	-7,287	Closed	-$264K	–	642
2023 Q3	$264K	Sell	7,287 -2,679	-27%	-$95.1K	0.02%	469
2023 Q2	$355K	Buy	9,966 +1,114	+13%	+$40K	0.02%	596
2023 Q1	$315K	Buy	8,852 +262	+3%	+$9.17K	0.02%	619
2022 Q4	$302K	Buy	8,590 +460	+6%	+$15.3K	0.02%	567
2022 Q3	$239K	Buy	+8,130	New	+$308K	0.01%	620
2022 Q2	–	Sell	-6,066	Closed	-$330K	–	747
2022 Q1	$330K	Buy	6,066 +20	+0.3%	+$1.09K	0.02%	552
2021 Q4	$333K	Buy	+6,046	New	+$315K	0.02%	569
2021 Q3	–	Sell	-4,769	Closed	-$237K	–	710
2021 Q2	$237K	Buy	+4,769	New	+$229K	0.01%	601

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CreativeOne Wealth's GSK Position: Q1 2026 in Review

CreativeOne Wealth reduced its GSK (GSK) stake by 5.3% in Q1 2026, selling an estimated $20.7K and leaving 6,838 shares worth $377K. The position accounts for 0.01% of the portfolio, ranked #897.

CreativeOne Wealth first reported a position in GSK in Q2 2021 and has held it in 15 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

CreativeOne Wealth held 6,838 shares of GSK worth $377K as of Q1 2026.
CreativeOne Wealth sold 382 GSK shares in Q1 2026, an estimated $20.7K.
GSK made up 0.01% of CreativeOne Wealth's portfolio in Q1 2026, its #897 holding.
CreativeOne Wealth first reported a position in GSK in Q2 2021 and has held it in 15 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.